Oruka Therapeutics Market Cap

Oruka Therapeutics has a market cap or net worth of $345.20 million as of April 17, 2025. Its market cap has increased by 632.91% in one year.

Market Cap

345.20M

Enterprise Value

-47.55M

1-Year Change

632.91%

Ranking

#3114

Market Cap Chart

Since December 1, 1998, Oruka Therapeutics's market cap has increased from $63.80M to $345.20M, an increase of 441.07%. That is a compound annual growth rate of 6.61%.

Market Cap History

Date	Market Cap	% Change
Apr 17, 2025	345.20M	-49.13%
Dec 31, 2024	678.60M	2,669.80%
Dec 29, 2023	24.50M	-28.36%
Dec 30, 2022	34.20M	10.32%
Dec 31, 2021	31.00M	-17.11%
Dec 31, 2020	37.40M	310.99%
Dec 31, 2019	9.10M	97.83%
Dec 31, 2018	4.60M	-71.07%
Dec 29, 2017	15.90M	-38.61%
Dec 30, 2016	25.90M	-38.48%
Dec 31, 2015	42.10M	108.42%
Dec 31, 2014	20.20M	-23.19%
Dec 31, 2013	26.30M	345.76%
Dec 31, 2012	5.90M	-43.81%
Dec 30, 2011	10.50M	-62.50%
Dec 31, 2010	28.00M	12.90%
Dec 31, 2009	24.80M	49.40%
Dec 31, 2008	16.60M	-82.99%
Dec 31, 2007	97.60M	-53.94%
Dec 29, 2006	211.90M	-38.20%
Dec 30, 2005	342.90M	7.80%
Dec 31, 2004	318.10M	19.27%
Dec 31, 2003	266.70M	1,240.20%
Dec 31, 2002	19.90M	-86.49%
Dec 31, 2001	147.30M	-24.77%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	754.27B
UnitedHealth Group	415.38B
Johnson & Johnson	379.48B
AbbVie	306.02B
Novo Nordisk	284.50B
Abbott Laboratories	227.16B
Novartis AG	209.93B
AstraZeneca	208.11B

Market Cap Rankings